IP Library Granted Patent US 8,757,148
Granted Patent B2
US 8,757,148 · App. 13/260,505 · Granted Jun 24, 2014

Devices and methods for engaging indexed valve and pressurized canister assembly with collar and for linear actuation by plunger assembly into fluid communication with device for regulating drug delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,757,148
App. No.
13/260,505
Granted
Jun 24, 2014
Kind
B2
Abstract

An indexed drug delivery device ( 70 ) comprising a valve assembly ( 13 ) comprising a housing ( 26 ) and a valve, the valve disposed within the housing, one or more keys ( 34,38 ) integral to the housing, the keys complementary to corresponding openings on a collar ( 12 ), a pressurized canister ( 28 ) in fluid communication with the valve assembly, the canister containing an active pharmaceutical ingredient and an inactive carrier gas, a receiving assembly comprising a receptacle adapted to engage at least a portion of the housing, a seat adapted to engage the valve, and, a plunger assembly adapted to linearly actuate the valve assembly and canister along an axis and to engage the valve and seat, the plunger assembly comprising a carriage fixed to the collar, and, a lever having a cam adapted to engage a spring, the spring adapted to linearly actuate the carriage, valve assembly, canister and collar along the axis.

Claims (49)

1. An indexed drug containment device assembly for a drug delivery and regulation device, the indexed drug containment device assembly comprising:

a portable gas canister containing an active pharmaceutical ingredient and an inactive gas carrier for delivery to a patient in need thereof via the drug delivery and regulation device,

a housing and a spring biased needle valve, the spring biased needle valve being disposed within the housing and regulating fluid flow from the portable gas canister by actuating along a longitudinal axis of the portable gas canister, and,

a first indexed member integral to the housing and comprising a first arcuate opening and a second arcuate opening that extend arcuately about, and on opposing sides of, the longitudinal axis of the portable gas canister, the first and second arcuate openings having at least one of different axial widths or misaligned mid planes, the first indexed member adapted to complementarily engage a second indexed member of the drug delivery and regulation device to provide sufficient engagement for actuation of the spring biased needle valve and so that the indexed drug containment device assembly seats into, and is removable from, the drug delivery and regulation device when aligned via a relative movement that is perpendicular to the longitudinal axis; and

wherein, when complementarily engaged, the indexed drug containment device assembly aligns, seals, opens, and is secured in the drug delivery and regulation device in a single movement.

2. The indexed drug containment device of claim 1 , wherein

the active pharmaceutical ingredient comprises at least one of:

nitric oxide, with a concentration in the range of approximately 50 ppm to 10,000 ppm,

carbon monoxide with a concentration in the range of approximately 500 ppm to 20,000 ppm, and,

a chalcogenide compound, and

the inactive carrier gas comprises at least one of N 2 and O 2 .

3. The indexed drug containment device of claim 1 , further comprising a radio frequency identification device adapted to communicate with a radio frequency receiver, wherein the radio frequency identification device is adapted to communicate to the radio frequency receiver identifying information of the contents of the portable gas canister that is attachable to the spring biased needle valve.

4. The assembly of claim 1 , wherein the first indexed member is configured to be a support enabling the indexed drug containment device assembly to be suspended vertically in the drug delivery and regulation device.

5. The assembly of claim 1 , wherein first indexed member is configured to be a support permitting actuation of the spring biased needle valve along the longitudinal axis of the portable gas canister.

6. The assembly of claim 1 , wherein, the first indexed member is configured to be a support enabling suspending the indexed drug containment device assembly in the drug delivery and regulation device and permitting actuation of the spring biased needle valve along the longitudinal axis of the portable gas canister.

7. The assembly of claim 1 , wherein one or more of the first indexed member and the second indexed member have a surface that is configured to be an at least one support enabling the indexed drug containment device assembly to be seated in the drug delivery and regulation device and permitting actuation of the spring biased needle valve along the longitudinal axis of the portable gas canister.

8. An indexed drug containment device assembly for a drug delivery and regulation device, the indexed drug containment device assembly comprising:

a portable gas canister containing a therapeutic gas drug for delivery to a patient in need thereof via the drug delivery and regulation device;

a spring biased needle valve disposed within a housing, the spring biased needle valve regulating fluid flow from the portable gas canister by actuating along a longitudinal axis of the portable gas canister;

a first indexed member integral to the housing comprising a first arcuate opening and a second arcuate opening arcuately about, and on opposing sides of, the longitudinal axis of the portable gas canister, the first and second arcuate openings having at least one of different axial widths or misaligned mid planes, the first indexed member being adapted to complementarily engage a second indexed member of the drug delivery and regulation device when aligned via a relative movement that is perpendicular to the longitudinal axis to (i) ensure the portable gas canister is at least one of the desired portable gas canister and containing the desired therapeutic gas drug, (ii) suspend the indexed drug containment device assembly in the drug delivery and regulation device, (iii) provide sufficient engagement to permit actuation of the spring biased needle valve; and

wherein, when complementarily engaged, the indexed drug containment device assembly aligns, seals, opens, and is secured in the drug delivery and regulation device in a single movement.

9. The assembly of claim 8 , further comprising: a radio frequency identification device adapted to communicate with a radio frequency receiver, wherein the radio frequency identification device is adapted to communicate to the radio frequency receiver identifying information of the contents of the portable gas canister that is attachable to the spring biased needle valve.

10. The assembly of claim 8 , wherein the portable gas canister comprises an active pharmaceutical ingredient including one of nitric oxide, with a concentration in the range of approximately 50 ppm to 10,000 ppm; carbon monoxide with a concentration in the range of approximately 500 ppm to 20,000 ppm; or, a chalcogenide compound, and an inactive carrier gas comprising at least one of N 2 and O 2 .

11. An indexed drug containment device assembly for a drug delivery and regulation device, the indexed drug containment device assembly comprising:

a spring biased needle valve disposed within a housing, the spring biased needle valve regulating fluid communication from a portable gas canister through a valve outlet by actuating along a longitudinal axis of the portable gas canister, the spring biased needle valve including an o-ring disposed within the valve outlet;

a first indexed member integral to the housing having a lower key ridge longitudinally opposite to an upper key ridge, the lower key ridge and the upper key ridge extending radially outward from, and arcuately about, the longitudinal axis forming a first arcuate opening and a second arcuate opening disposed on opposite sides of the longitudinal axis and having at least one of different axial widths or misaligned mid planes;

the first opening and the second opening of the first indexed member adapted to be complementary to a first collar key and a second collar key of a second indexed member, respectively, when aligned with the second indexed member along a direction perpendicular to the longitudinal axis to (i) ensure the portable gas canister is at least one of the desired portable gas canister and containing the desired therapeutic gas drug, (ii) suspend the indexed drug containment device assembly in the drug delivery and regulation device, (iii) provide sufficient engagement to permit actuation of the spring biased needle valve; and

wherein, when complementarily engaged, the indexed drug containment device assembly is configured to interact with a seat of the drug delivery and regulation device that is advanced along the longitudinal axis by a single levering movement so that:

i. the valve outlet is aligned to receive the axially advancing seat;

ii. the o-ring, disposed within the valve outlet, forms a seal by receiving the axially advancing seat through the valve outlet and subsequently through the o-ring;

iii. the valve is then actuated along the longitudinal axis by the axially advancing seat, thus allowing fluid flow through the valve outlet; and

iv. the indexed drug containment device assembly is secured in the drug delivery and regulation device.

12. The assembly of claim 11 , further comprising: a radio frequency identification device adapted to communicate with a radio frequency receiver, wherein the radio frequency identification device is adapted to communicate to the radio frequency receiver identifying information of the contents of the portable gas canister that is attachable to the spring biased needle valve.

13. The assembly of claim 11 , wherein the portable gas canister comprises an active pharmaceutical ingredient including one of nitric oxide, with a concentration in the range of approximately 50 ppm to 10,000 ppm; carbon monoxide with a concentration in the range of approximately 500 ppm to 20,000 ppm; or, a chalcogenide compound and an inactive carrier gas comprising at least one of N 2 and O 2 .

14. An indexed drug delivery system, comprising:

an indexed drug containment device assembly comprising:

a housing having an external surface and containing a spring biased needle valve, the spring biased needle valve regulating fluid communication from a portable gas canister through a valve outlet located along a longitudinal axis of the portable gas canister and including an o-ring disposed within the valve outlet, and

a first indexed member integral to the housing, the first indexed member comprising:

a first opening that is arcuate about a side of the external surface of the housing and extending radially inward from the side of the external surface of the housing, and

a second opening that is arcuate about an another side of the external surface of the housing and extending radially inward from the another side of the external surface of the housing;

a drug delivery and regulation device for delivering a gas comprising an active pharmaceutical ingredient to a patient in need thereof, the drug delivery and regulation device comprising:

a second indexed member having a first collar key and a second collar key, and

a seat;

wherein the first opening and the second opening of the first indexed member are configured to be complementary to the first collar key and the second collar key of the second indexed member, respectively, when aligned along a direction perpendicular to the longitudinal axis to provide sufficient engagement for actuation of the spring biased needle valve and so the indexed drug containment device assembly is insertable and removable from the drug delivery and regulation device via a relative movement that is perpendicular to the longitudinal axis; and

wherein, when inserted in the drug delivery and regulation device, the indexed drug containment device assembly is configured to interact with the seat of the drug delivery and regulation device that is advanced along the longitudinal axis by a single levering movement so that:

(i) the valve outlet is aligned to receive the axially advancing seat;

(ii) the o-ring, disposed within the spring biased needle valve, forms a seal by receiving the axially advancing seat through the valve outlet and subsequently through the o-ring;

(iii) the spring biased needle valve is then actuated along the longitudinal axis by the axially advancing seat, thus allowing fluid flow through the valve outlet; and

(iv) the indexed drug containment device assembly is secured in the drug delivery and regulation device.

Assignments (35)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2026
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED COMPANY
Reel/Frame 075393/0608 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 73375 FRAME 395. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 075021/0263 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCLUSION OF US PATENT 10828415 AND REMOVE IT FROM THE LISTING PREVIOUSLY RECORDED ON REEL 72331 FRAME 1. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 6, 2026
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 075021/0204 →
SECURITY INTEREST Recorded Oct 28, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 073375/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2025
From: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 072040/0424 →
CHANGE OF NAME Recorded Aug 16, 2025
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY
Reel/Frame 072477/0834 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: SPECGX LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 072331/0001 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 049822, FRAME 0674 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0454 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 035454, FRAME 0768 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0035 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
RELEASE OF SECURITY INTEREST Recorded Jun 17, 2022
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS, INC.; MALLINCKRODT LLC; MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY); SPECGX LLC; STRATATECH CORPORATION; VTESSE LLC (F/K/A VTESSE INC.)
Reel/Frame 060389/0839 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
SECURITY INTEREST Recorded Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY; STRATATECH CORPORATION; VTESSE INC.; MALLINCKRODT LLC
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jul 22, 2019
From: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049822/0674 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2016
From: INO THERAPEUTICS LLC
To: THERAKOS, INC.
Reel/Frame 038008/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2016
From: MALLINCKRODT IP
To: MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
Reel/Frame 038009/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2016
From: MALLINCKRODT PHARMA IP TRADING DAC
To: MALLINCKRODT IP
Reel/Frame 038009/0058 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2016
From: MALLINCKRODT CRITICAL CARE FINANCE INC.
To: MALLINCKRODT PHARMA IP TRADING DAC
Reel/Frame 038038/0009 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2016
From: THERAKOS, INC.
To: MALLINCKRODT CRITICAL CARE FINANCE INC.
Reel/Frame 038008/0824 →
SECURITY INTEREST Recorded Apr 19, 2015
From: INO THERAPEUTICS LLC
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 035454/0768 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: INO THERAPEUTICS LLC
Reel/Frame 035453/0487 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: INO THERAPEUTICS LLC
Reel/Frame 035453/0513 →
PATENT SECURITY AGREEMENT (SECOND LIEN) Recorded Mar 11, 2014
From: INO THERAPEUTICS LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 032426/0848 →
PATENT SECURITY AGREEMENT (FIRST LIEN) Recorded Mar 11, 2014
From: INO THERAPEUTICS LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 032426/0747 →
RELEASE OF SECURITY INTEREST Recorded Feb 18, 2014
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
To: INO THERAPEUTICS LLC
Reel/Frame 032274/0768 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2014
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
To: IKARIA INC.; INO THERAPEUTICS LLC
Reel/Frame 032264/0517 →
SECURITY AGREEMENT Recorded Jul 10, 2013
From: IKARIA, INC.; IKARIA ACQUISITION INC.; INO THERAPEUTICS LLC
To: CREDIT SUISSE AG, AS COLLATERAL AGENT
Reel/Frame 030764/0549 →
SECURITY AGREEMENT Recorded Jul 9, 2013
From: IKARIA, INC.; IKARIA ACQUISITION INC.; INO THERAPEUTICS LLC
To: CREDIT SUISSE AG, AS COLLATERAL AGENT
Reel/Frame 030764/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2012
From: IKARIA, INC.
To: INO THERAPEUTICS, LLC
Reel/Frame 027622/0865 →
CHANGE OF NAME Recorded Jan 31, 2012
From: IKARIA HOLDINGS, INC.
To: IKARIA, INC.
Reel/Frame 027621/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2012
From: MONTGOMERY, FREDERICK J.; BATHE, DUNCAN P.; LEE, DANIEL J.; BIBA, SCOTT I.; BAKKEN, TODD J.
To: IKARIA, INC.
Reel/Frame 027622/0697 →